Genmab A/S (GMAB)
25.82
-0.21
(-0.81%)
USD |
NASDAQ |
Mar 27, 16:00
25.82
0.00 (0.00%)
After-Hours: 20:00
Genmab EPS Diluted (Quarterly) : 0.0461 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.9419 |
| AbbVie, Inc. | 1.018 |
| Ascendis Pharma A/S | -0.6364 |
| Zealand Pharma A/S | -0.8368 |
| Bavarian Nordic A/S | -0.1983 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 30.98M |
| Revenue (Quarterly) | 1.057B |
| Total Expenses (Quarterly) | 1.026B |
| Enterprise Value | 19.62B |
| Gross Profit Margin (Quarterly) | 92.34% |
| Profit Margin (Quarterly) | 2.93% |
| Earnings Yield | 6.00% |
| Operating Earnings Yield | 7.62% |
| Normalized Earnings Yield | 6.740 |